• Trump approves emissions exemptions for some chemical, taconite iron ore facilities
• EPA Readied a Report on One Forever Chemical. Now It's in Limbo.

"Cancer rates among young adults in the Corn Belt, a patchwork of golden fields and straight-line highways stretching across the heart of the Midwest, are rising more rapidly than in the country as a whole, a Washington Post data analysis reveals." [_link]

— Meryl Kornfield (@MerylKornfield) October 27, 2025

Physician Gabor Mate Gives His Analysis on ADHD and Anxiety [_link]

— Benjamin (@MrBenBrown) September 14, 2022

Why are diagnoses of ADHD soaring? There are no easy answers - but empathy is the place to start | The Guardian Opinion by Gabor Maté |

Consensus is lacking about almost every aspect of ADHD. While it has become the object of an intellectual free-for-all as to its nature, neurobiology, origins - and, in some circles, even its validity - the diagnosis is burgeoning internationally. Among children in China, for instance, it has been called "an increasing public health concern". In Germany, rates increased almost fourfold in a little over a decade. In the UK, prescriptions for ADHD medications have risen 18% each year since the pandemic. Similar trends are seen in North America.

Whatever the accuracy of such statistics, it is evident that throughout the globalised world more and more children are struggling with attention challenges, emotional instability, learning disabilities and behaviour regulation, to say nothing of the panoply of other diagnoses such as spectrum disorders, anxiety, "oppositionality", depression or the catch-all phrase, "neurodivergence".